147 related articles for article (PubMed ID: 2095905)
1. [Search for antibodies against human immunodeficiency virus type 2 (HIV-2) in a sample of parenteral drug addicts (IVDA)].
Ortiz de Lejarazu R; Eiros JM; Perlado del Campo E; Palenzuela MS; Reguera JI; Rodríguez-Torres A
Enferm Infecc Microbiol Clin; 1990 Jan; 8(1):48-51. PubMed ID: 2095905
[TBL] [Abstract][Full Text] [Related]
2. [Evidence of infection by HIV-2 in Madrid (1991)].
Gutiérrez M; Soriano V; Oliván M; Lago M; Puente S; Baquero M; González-Lahoz JM
An Med Interna; 1992 Mar; 9(3):111-5. PubMed ID: 1567945
[TBL] [Abstract][Full Text] [Related]
3. [Serology of the human immunodeficiency virus in saliva].
Cárcaba V; Fernández E; Rodríguez Junquera M; García Amorín Z; Alfonso J; García Alonso S
Med Clin (Barc); 1993 Jul; 101(6):205-6. PubMed ID: 8332019
[TBL] [Abstract][Full Text] [Related]
4. [Evidence of infection by type 2 (HIV 2) human immunodeficiency virus in heroin addicts in Barcelona].
Soriano V; Tor J; Ribera A; Clotet B; Muga R; Martín J; Foz M
Med Clin (Barc); 1989 Sep; 93(6):204-6. PubMed ID: 2601478
[TBL] [Abstract][Full Text] [Related]
5. [Prevalence of anti-HIV-2 antibodies in a population at risk attending the drug-dependence center of the Rho hospital].
Albert F; Corazza M; Rotondi L; Segrè C
Boll Ist Sieroter Milan; 1989; 68(2):122-6. PubMed ID: 2577476
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of the Abbott recombinant HIV-1/HIV-2 enzyme immunoassay for the detection of HIV antibodies.
Gershy-Damet GM; Kodjo M; Benoit S
AIDS; 1990 Jan; 4(1):87-8. PubMed ID: 2156529
[No Abstract] [Full Text] [Related]
7. Immunofluorescence, enzyme-linked immunosorbent assay, particle agglutination and western blot for the detection of antibody to human immunodeficiency virus type 1.
Auwanit W; Ayuthaya PI; Balachandra K; Jayavasu C; Phanthumachinda B; Ikuta K; Yamanishi K; Kanai K
Southeast Asian J Trop Med Public Health; 1990 Mar; 21(1):53-9. PubMed ID: 2205928
[TBL] [Abstract][Full Text] [Related]
8. Identification of human immunodeficiency virus type 2 in a New Zealand resident.
Shroeder BA; Bridle M; Croxson MC; Franklin R
N Z Med J; 1994 Jun; 107(979):217-9. PubMed ID: 8208481
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a rapid test for the detection of antibodies to human immunodeficiency virus type 1 and 2.
Ng KP; Saw TL; Baki A; He J; Singh N; Lyles CM
Int J STD AIDS; 1999 Jun; 10(6):401-4. PubMed ID: 10414883
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
[TBL] [Abstract][Full Text] [Related]
11. Early detection of antibodies to human immunodeficiency virus 1 by a third-generation enzyme immunoassay. A comparative study with the results of second-generation immunoassays and western blot.
Barbé F; Klein M; Badonnel Y
Ann Biol Clin (Paris); 1994; 52(5):341-5. PubMed ID: 7856933
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence of human immunodeficiency virus type 1 and Mycobacterium tuberculosis infections in a prison population in the years 1989 to 1995].
Pérez-Agudo F; Alonso Moreno FJ; Urbina Torija J
Med Clin (Barc); 1998 Feb; 110(5):167-70. PubMed ID: 9547719
[TBL] [Abstract][Full Text] [Related]
13. [Human immunodeficiency virus type 2 infection in Western Africans living in Catalonia].
Soriano V; Tor J; Muga R; Fernández JL; Ribera A; Balanzó X; Foz M
Med Clin (Barc); 1989 Feb; 92(5):161-3. PubMed ID: 2657255
[TBL] [Abstract][Full Text] [Related]
14. Field evaluation of the Merlin immediate HIV-1 and -2 test for point-of-care detection of human immunodeficiency virus antibodies.
Shafran SD; Conway B; Prasad E; Greer J; Vincelette J; Ellis CE; Haase DA; Walmsley SL; Lalonde RG; Cameron DW
Clin Infect Dis; 2002 Mar; 34(5):658-61. PubMed ID: 11823955
[TBL] [Abstract][Full Text] [Related]
15. Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein.
Norrby E; Chiodi F; Whalley A; Parks E; Nauclér A; Costa CM; Torstensson R; Biberfeld G
AIDS; 1989 Jan; 3(1):17-20. PubMed ID: 2469436
[TBL] [Abstract][Full Text] [Related]
16. HIV antibodies among intravenous drug users in Bahrain.
al-Haddad MK; Khashaba AS; Baig BZ; Khalfan S
J Commun Dis; 1994 Sep; 26(3):127-32. PubMed ID: 7868834
[TBL] [Abstract][Full Text] [Related]
17. No evidence of HIV 2 infection in Sicily.
Russo Alesi D; Vitale F; Lupo G; La Licata R; Zambito F; Romano N
Microbiologica; 1989 Jul; 12(3):195-201. PubMed ID: 2674633
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of HIV-1 infection in intravenous drug dependent patients 1986 to 1989 in Vienna].
Loimer N; Presslich O; Hollerer E; Werner E; Pakesch G; Pfersmann V; Schmid-Siegel B; Aschauer G
Wien Klin Wochenschr; 1990 Feb; 102(4):106-10. PubMed ID: 2316224
[TBL] [Abstract][Full Text] [Related]
19. [Could saliva be used to detect HIV seroconversion?].
Sangaré KA; Koffi AR; Coulibaly IM; Doulourou C
Sante; 1997; 7(5):303-7. PubMed ID: 9480036
[TBL] [Abstract][Full Text] [Related]
20. Interpretive criteria used to report western blot results for HIV-1-antibody testing--United States.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1991 Oct; 40(40):692-5. PubMed ID: 1656186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
